- Citius Pharmaceuticals Inc at Sidoti & Company January Micro-Cap Virtual Conference TranscriptJan 18, 2023
- Citius Pharmaceuticals Inc at ThinkEquity Conference TranscriptOct 26, 2022
- Citius Pharmaceuticals Inc at Dawson James Small Cap Growth Conference TranscriptOct 12, 2022
- Citius Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Citius Pharmaceuticals Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Citius Pharmaceuticals Inc at Benzinga Virtual Global Small Cap Conference TranscriptMay 13, 2021
- Citius Pharmaceuticals Inc Corporate Analyst Meeting TranscriptDec 06, 2020
- Citius Pharmaceuticals Inc CEORoadshow Interview with Leonard Mazur TranscriptJul 10, 2020
- Citius Pharmaceuticals Inc at Noble Capital Markets Small and Microcap Investor Conference TranscriptFeb 16, 2020
Citius Pharmaceuticals Inc at Noble Capital Markets Small and Microcap Investor Conference Transcript
-- the fact that you're able to come to our meeting, I have realize you had multiple choices here and hopefully you'll find this to be worthwhile.
First of all, we have the usual disclaimer statement, but I do strongly encourage everybody to consult our website as well as sec.gov for any and all information on the company. We are in Nasdaq and so we are a fully reporting company.
In terms of the company itself, we have some great opportunities. We are different from other pharma companies in effect in a sense that there's some unique aspects to us.
First of all, we have late-stage assets. Our lead asset is a Phase 3 drug. We have a large market opportunity with -- where there are unmet needs and will be, upon approval, the only products in the marketplace. So that makes us, separates us from the rest of the pack.
We do have, as I always like to say, we have an expert team, but what separates us from everybody else is the fact that our team has put in its own money into the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)